Absence of Viral Replication in HCV-Associated HCC: A Pathway to Improved Outcomes

Hazem Abosheaishaa; Khalid Al-Naamani; Mohamed El-Kassas

doi:10.1111/liv.16225

Absence of Viral Replication in HCV-Associated HCC: A Pathway to Improved Outcomes

Liver Int. 2025 Feb;45(2):e16225. doi: 10.1111/liv.16225.

Authors

Hazem Abosheaishaa¹, Khalid Al-Naamani², Mohamed El-Kassas³

Affiliations

¹ Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City Health and Hospitals, Queens Hospital Center, New York, New York, USA.
² Department of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat, Oman.
³ Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.

PMID: 39777997
DOI: 10.1111/liv.16225

No abstract available

Keywords: direct‐acting antivirals (DAAs); hepatitis C virus (HCV); hepatocellular carcinoma (HCC); sustained virological response (SVR); viral replication.

Publication types

Editorial